Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients

被引:0
|
作者
Watanabe, Fumiaki
Suzuki, Koichi
Endo, Yuhei
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
关键词
D O I
10.1200/JCO.2019.37.4_suppl.254
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
254
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients
    Watanabe, Fumiaki
    Suzuki, Koichi
    Ishikawa, Hideki
    Kakizawa, Nao
    Rikiyama, Toshiki
    CANCER SCIENCE, 2018, 109 : 711 - 711
  • [2] Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients
    Watanabe, Fumiaki
    Suzuki, Koichi
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] Clinical significance of monitoring KRAS in tissue and serum of pancreatic cancer patients.
    Watanabe, Fumiaki
    Suzuki, Koichi
    Ishikawa, Hideki
    Endo, Yuhei
    Ichida, Kosuke
    Takayama, Yuji
    Fukui, Taro
    Kakizawa, Nao
    Kasahara, Naoya
    Kato, Takaharu
    Noda, Hiroshi
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Clinical significance of monitoring KRAS in the blood of pancreatic cancer patients.
    Watanabe, Fumiaki
    Suzuki, Koichi
    Ichida, Kosuke
    Takayama, Yuji
    Fukui, Taro
    Kakizawa, Nao
    Endo, Yuhei
    Kaneda, Yuji
    Noda, Hiroshi
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] The clinical significance of KRAS monitoring in tumor tissues and blood of patients with pancreatic tumor.
    Walter, Dirk
    Döring, Claudia
    Feldhahn, Magdalena
    Battke, Florian
    Hartmann, Sylvia
    Winkelmann, Ria
    Noda, Hiroshi
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [6] Clinical significance of plasma metastin level in pancreatic cancer patients
    Katagiri, Fumihiko
    Nagai, Kazuyuki
    Kida, Atsushi
    Tomita, Kenji
    Oishi, Shinya
    Takeyama, Masaharu
    Doi, Ryuichiro
    Fujii, Nobutaka
    ONCOLOGY REPORTS, 2009, 21 (03) : 815 - 819
  • [7] Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
    Tjensvoll, Kjersti
    Lapin, Morten
    Buhl, Tove
    Oltedal, Satu
    Berry, Katrine Steen-Ottosen
    Gilje, Bjornar
    Soreide, Jon Arne
    Javle, Millind
    Nordgard, Oddmund
    Smaaland, Rune
    MOLECULAR ONCOLOGY, 2016, 10 (04) : 635 - 643
  • [8] DETECTION AND CLINICAL SIGNIFICANCE OF THROMBOMODULIN IN BOTH PLASMA AND TISSUE EXTRACTS OF CANCER PATIENTS
    许晓华
    卢兴国
    徐根波
    朱蕾
    黄连生
    Chinese Journal of Cancer Research, 2004, (02) : 30 - 33
  • [9] Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer
    An, Ji Yeong
    Choi, Min-Gew
    Noh, Jae Hyung
    Sohn, Tae Sung
    Jin, Dong-Kyu
    Kim, Sung
    JOURNAL OF SURGICAL RESEARCH, 2007, 143 (02) : 344 - 349
  • [10] Detection and clinical significance of thrombomodulin in both plasma and tissue extracts of cancer patients.
    Xu, XH
    Huang, LS
    Lu, XG
    Zhang, XH
    Zhao, XY
    BLOOD, 2004, 104 (11) : 77B - 78B